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Abstract  Inﬂammatory  syndrome  is  one  of  the  rare  emergency  breast  situations.  Its  etiology
is benign,  infectious  in  most  cases.  The  clinical  examination  is  often  self-evident  and  suggests
the diagnosis.  But  alone  it  is  insufﬁcient,  and  diagnostic  tests  are  necessary  to  guide  therapy.  As
essential as  it  is,  mammography’s  limitations  reinforce  the  beneﬁt  of  ultrasonography,  which  in
all cases  reveals  an  abscess  and  has  greater  sensitivity  for  detecting  a  malignant  tumor.  If  the
etiology is  benign,  clinical  signs  will  disappear  with  medical  treatment,  with  no  need  for  further
investigation.  While  it  is  legitimate  to  initiate  a  trial  treatment,  it  must  not  delay  oncologic
management,  because  of  the  severity  of  inﬂammatory  cancer.
© 2011  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Since  the  breast  is  a  superﬁcial  organ,  inﬂammation  or  mastitis  results  in  classical  clinical
signs:  redness,  heat,  and  pain.  It  is  a  rare  reason  for  consultation  with  a  physician.  Mastitis
has  several  possible  etiologies:  pure  inﬂammatory,  infectious,  or  malignant  [1,2]. It  is  an
emergency  breast  situation.  Any  picture  of  mammary  infection  that  initially  appears  to  be
benign  but  resists  appropriate  treatment  should  suggest  a malignant  lesion.There  are  few  series  in  the  literature  addressing  the  value  of  various  imaging  studies  for
diagnosing  inﬂammatory  syndrome,  whose  management  includes  the  possibility  of  surgical
procedures.  When  malignancy  is  conﬁrmed,  it  must  be  managed  in  an  oncologic  setting  on
an  emergency  basis.
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Figure 1. Age 47. Left breast red, taut, entirely indurated: a: mammogram, standard lateral: marked sloping skin thickening, areolar
appearance of the structure, focal increase supra-areolar density at mid third of the gland, cluster of irregular microcalciﬁcations; b: lateral
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Mimage enlarged to better analyze the microcalciﬁcations. The increa
irregular 35 mm supra-areolar mass. Ultrasound-guided microbiopsy
Overview: contribution and limitations of
the  clinical examination and conventional
imaging
The clinical examination
Redness,  measured  in  centimeters,  is  not  marked,  and  is
localized  in  inﬂammatory  cysts  and  diabetic  mastopathy;
however,  redness  or  lack  thereof  is  not  proof  positive  of
benignity.  ‘‘Orange  peel’’  (pitting)  edema  may  or  may  not  be
present  in  benign  causes,  and  is  signiﬁcantly  more  marked
in  infectious  and  malignant  mastitis  than  in  purely  inﬂam-
matory  mastitis  [3].The  abscess  presents  as  a  classically  ﬂuctuating  tumor,
but  this  sign  is  actually  rare  here,  since  the  Cooper’s  lig-
aments  act  as  a  barrier  against  the  spread  of  infection  to
the  surface,  and  the  infection  most  often  spreads  inside  the
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socal density is located at the upper edge of the ﬁlm; c: ultrasound:
asive ductal carcinoma.
land,  which  cannot  be  judged  from  its  external  appear-
nce  [4].  Purulent  discharge,  fever,  and  laboratory  signs  are
enerally  absent  with  mammary  abscesses.
Palpation  of  a  thickness  or  mass(es)  is  not  necessarily  a
ad  sign,  and  may  reﬂect  dilated  pseudocystic  ducts  or  dia-
etic  mastopathy.  Conversely,  in  inﬂammatory  cancer,  an
nderlying  mass  is  not  always  palpated.  Whence  the  impor-
ance  of  imaging  in  making  an  etiologic  diagnosis.
maging
riority  of  studies
ammography  is  essential  in  adult  females.  It  can  be
ifﬁcult  to  perform  and  interpret  if  there  is  insufﬁcient
ompression  and  if  there  is  marked  edema,  giving  the  struc-
ure  a  mesh-like  appearance.  When  clinical  and  ultrasound
igns  are  in  favor  of  benignity,  it  is  better  to  perform  one
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Figure 2. Age 44, inﬂammatory right breast, more marked lateral supra-areolar induration: a: right mammogram, frontal: thickening
of the skin, areolar aspect of the structure, extensive architectural distortion at the lateral quadrants. ACR 5; b: right mammogram,
lateral: thickening of the nipple and areola due to edema, extensive architectural distortion at the superior lateral quadrant. Irregular
microcalciﬁcations difﬁcult to locate; c: left mammogram, lateral: For comparison. ACR 1; d: ultrasound, junction of right lateral quadrants:
5 mm skin thickening, visibility of subcutaneous lymphatic vessels, which follow the path of a crest of Duret, hyperechoic appearance
of fat lobules; e: ultrasound centered on the right superior lateral quadrant: skin thickening, tubular structures parallel to the skin,
corresponding to dilated lymphatic vessels, poorly delimited parenchymal area with echogenic spots corresponding to microcalciﬁcations.
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mltrasound-guided microbiopsy: invasive ductal carcinoma.
econdarily,  after  the  inﬂammation  resolves,  in  order  to
btain  a  good  quality  study.  Mammograms  are  typically  per-
ormed  in  women  after  30  years  of  age  [5],  but  should  be
erformed  in  a  young  woman  under  30  when  there  are  sus-
icious  clinical  signs  or  persistent  inﬂammation.
The  signs  of  edema  are  often  mild,  predominantly  in  the
eriareolar  area  and  in  the  inferior  quadrants  due  to  grav-
ty;  sometimes  it  is  necessary  to  make  a  comparison  with
he  opposite  side.  By  increasing  the  contrast,  digital  mam-
ography  facilitates  the  detection  of  subtle  signs.
We  look  for  the  following  signs,  which  are  then  described
sing  the  BI-RADS  lexicon:
(
t
t
ldilated  retroareolar  ducts;
calciﬁcations;
focal  asymmetric  density  (Fig.  1a  and  b);
mass.
Ultrasonography  is  the  ﬁrst-line  method  used  when  mam-
ography  is  not  feasible,  or  in  addition  to  mammographyFig.  1c).  The  signs  common  to  all  inﬂammation  are:  skin
hickening  to  more  than  3  mm,  a  hyperechoic  appearance  of
he  fat  lobules  due  to  edema,  visibility  of  the  subcutaneous
ymphatic  vessels  in  the  form  of  tubular  structures  that
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Figure 3. Age 32. Smoker: a: right periareolar inﬂammatory syndrome; 
abscess resolved with medical treatment.
follow  the  path  of  the  crests  of  Duret  (Fig.  2).  We  look  for
the  following  signs  [3]:
• dilated  lactiferous  ducts  (more  than  3  mm  in  diameter);
• cysts  (by  analyzing  echogenicity,  wall  thickness)
• ﬂuid  collections  and  ﬁstulas  (Fig.  3);
• solid  masses  (Fig.  4);
• enlarged  axillary  lymph  nodes.
Contribution  and  limitations  of  imaging  in  reaching
an etiologic  diagnosis
The  imaging  signs  of  edema  are  signiﬁcantly  more  marked
in  infectious  and  malignant  mastitis  than  in  purely  inﬂam-
matory  mastitis  [3].  A  benign  inﬂammatory  lesion  generally
has  no  suspicious  manifestation  [4].
Figure 4. Age 46; localized left supra-areolar inﬂammatory syn-
drome. Mammogram: dense breasts, mild signs of edema, ACR 2.
Ultrasound: moderate skin thickening, dilatation of subcutaneous
lymphatic vessels, irregular 30 mm mass, ACR 5. Ultrasound-guided
microbiopsy: grade 2 invasive ductal carcinoma.
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sb: ﬁrst-line ultrasound: dilated duct with thick contents. Periareolar
ammography
he  mammogram  may  be  normal  (ACR  1).  The  abscess  is
ccult  in  one-third  of  all  cases  on  the  mammogram  [4,6].
he  mammogram’s  sensitivity  for  detecting  inﬂammatory
ancer  varies  in  the  literature,  ﬁrstly  due  to  technical  differ-
nces  and  secondly  due  to  the  individualization  of  primary
nﬂammatory  cancer  as  compared  to  locally  advanced  can-
er  with  secondary  inﬂammatory  changes.  Mammography
oes  not  necessarily  reveal  a  mass  that  correlates  with
he  palpable  mass  found  in  most  patients.  In  the  study
y  Le-Petross  [7],  compared  with  other  imaging  meth-
ds,  mammography  had  the  lowest  cancer  detection  rate
43%  of  single  and  multiple  masses  detected).  But  in  those
ases,  the  edema  was  often  marked  and  the  gland  had
ncreased  density:  the  mammogram  could  not  be  considered
ormal.
The  mammogram  may  show  signs  of  duct  ectasia  (ACR  2).
n  that  case  it  is  necessary  to  ascertain  that  the  ectasia  is
he  only  causal  mechanism  of  the  inﬂammatory  syndrome,
ince  it  is  commonplace  to  see  these  signs  without  any
ymptoms.
The  mammogram  may  show  changes  in  gland  density.
ery  moderate  diffuse  edema  and  a  focal  increased  den-
ity  that  is  difﬁcult  to  isolate  argue  in  favor  of  benignity.  A
iffuse  increase  in  density  is  more  suspicious  and  can  mask
 malignant  mass,  as  mentioned  above  [7—9].
There  may  be  an  architectural  distortion  (ACR  4),  which
ay  be  slight,  due  to  plasmacytic  mastitis  with  ﬁbrosis,  or
arked,  posing  a  more  acute  problem  for  differential  diag-
osis  versus  malignant  disease.  Percutaneous  biopsies  are
ecessary  when  there  is  image  distortion,  and  the  choice  of
echnique  is  determined  based  on  whether  or  not  the  image
ppears  on  the  ultrasound.
The  mammogram  may  be  classiﬁed  ACR  5  from  the  outset
Fig.  2).  Technological  progress  has  contributed  to  its  better
ensitivity  in  malignant  inﬂammatory  syndrome.
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wigure 5. Age 61, lumpectomy (invasive lobular carcinoma) 1 mo
car. First-line ultrasound. a: thickening of skin, dilatation of subcu
n abscess; b: irregular hyperechoic area. Abscess. Medical treatm
ltrasonography
he  ultrasound  signs  are  mild  or  even  absent  when  the
bscess  is  in  the  presuppurative  stage.  However  an  abscess
ith  collection  of  pus  always  appears  on  the  ultrasound  [6]
Fig.  5).  While  the  analysis  of  a  mass  is  based  on  the  BI-
ADS  lexicon  and  classiﬁcation,  management  should  reﬂect
he  clinical  context,  since  the  ultrasound  signs  of  an  abscess
echogenic  halo,  etc.)  have  a  high  positive  predictive  value
or  malignancy.  An  inﬂammatory  syndrome  manifesting  as
 very  hypoechoic  or  irregular  anechoic  area  that  appears
enign  or  indeterminate  on  the  mammogram,  is  assumed  to
ave  a  benign  etiology  [4].The  abscess  may  still  pose  a  differential  diagnosis  prob-
em  versus  a  malignant  mass  due  to  its  irregular  shape
nd  ill-deﬁned  margin  [5].  It  should  be  borne  in  mind
hat  rapidly  progressive  cancers  (with  a  triple-negative
D
T
igure 6. Age 65, left breast globally indurated and red. Mammogram
ith swirling echoes and large colored pedicles. Ultrasound-guided micrearlier. Onset of redness and medial periareolar thickening below
ous lymphatic vessels, parenchymal ﬂuid collections suggestive of
as initiated.
henotype  and/or  occurring  in  mutated  women  in  whom
alignant  tumors  with  a  pseudo-ﬂuid  appearance  on  the
ltrasound  have  been  reported)  are  very  hypoechoic  in
ature  [10,11]. Finally,  necrotic  cancer  can  have  a  pseudo-
uid  appearance  with  swirling  echoes  (Fig.  6).
Even  in  patients  who  have  only  a  mild  image  on
he  mammogram,  the  ultrasound  can  show  a  mass  with
ll  the  criteria  for  malignancy,  or  extensive  architec-
ural  disorganization.  The  sensitivity  of  ultrasonography  in
nﬂammatory  syndrome  is  65%  [9].  It  is  therefore  an  alter-
ative  to  mammography  when  the  latter  is  not  technically
easible.iagnostic strategy
his  is  summarized  in  Fig.  7.
 not feasible. Ultrasound (a, b): multiple very hypoechoic masses
obiopsy: necrotic invasive ductal carcinoma.
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fFigure 7. Course of action for inﬂammatory syndrome of non-rar
Benign-appearing inﬂammatory syndrome
An  emergency  trial  treatment  is  prescribed  for  10—15  days
after  which  the  patient  is  seen  again  for  a  clinical  examina-
tion  and  follow-up  ultrasound  (as  well  as  a  mammogram,  if
one  was  not  done  originally).  The  need  for  follow-up  should
be  clearly  indicated  in  the  conclusion  of  the  radiology  report
and,  ideally,  an  appointment  should  be  scheduled  for  the
patient.
When  the  clinical  radiology  aspect  suggests  an  abscess,  a
bacteriology  specimen  is  not  essential,  but  makes  it  possible
to  adjust  the  antibiotic  therapy.  The  puncture  is  done  with
i
•
•logy.
n  18G  or  20G  needle;  the  specimens  are  cultured  on  aerobic
nd  anaerobic  media.
Persistent  clinical  inﬂammation  or  mass-type  abnormal-
ties  on  the  ultrasound  are  indications  for  an  ultrasound-
uided  14G  biopsy.  A  residual  granuloma  is  simply  monitored
Fig.  8).
A  14G  microbiopsy  sometimes  reveals  cystic  and  ectatic
eatures,  but  the  clinical  signs  improve  without  disappear-
ng,  suggesting  inﬂammatory  cancer.  Possible  options  are:
macrobiopsies  to  provide  larger  samples;
or  an  MRI,  which  is  indicated  after  treatment  of  inﬂam-
matory  syndrome,  if  in  doubt  about  the  diagnosis,  even
132  
Figure 8. Age 45. Follow-up on an abscess after 10 days of med-
ical treatment. Ultrasound: solid 1 cm mass with well deﬁned
margins. Ultrasound-guided microbiopsy: granuloma. Follow-up:
4 months, 6 months, then usual.
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sometimes  difﬁcult,  since  this  is  a  poorly  deﬁned  mass  with
posterior  acoustic  shadowing.  Radiologic/histologic  recon-
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igure 9. Slightly marked localized inﬂammatory syndrome, persistin
ugmentation implants. Ultrasound: bilateral intracapsular rupture. MRI,
art of the implant. a: T1-weighted, without injection: the siliconoma is m
f the siliconoma, due to inﬂammatory phenomena. Regression of signs 
igure 10. Age 52. Right breast globally red, hard, very enlarged. Ma
ith medical treatment. An MRI was ordered. a: MRI of right breast, T2
ymphatic vessels that ‘‘outline’’ the path of the crests of Duret; b: MRI, c
uadrant are heterogeneously enhanced. ACR 5. Blind microbiopsy at rigM.  Boisserie-Lacroix  et  al.
if  differentiation  between  benign  and  malignant  mastitis
remains  difﬁcult  [12]  (Figs.  9  and  10).
A  suspicion  of  diabetic  mastopathy  leads  to  an
ltrasound-guided  14G  microbiopsy  and,  if  the  diagnosis  is
istologically  conﬁrmed,  it  seems  possible  to  avoid  a  surgical
rocedure  [13].
In the  context  of  a  treated  breast  (conservative
reatment),  the  diagnostic  process  is  different,  since  post-
adiation  inﬂammation  is  the  initial  hypothesis  (Fig.  11).
 normal  workup  supports  that  hypothesis,  and  medical
reatment  (nonsteroidal  anti-inﬂammatories  and  ice)  should
ake  the  clinical  signs  disappear.
mbiguous or suspicious-appearing
nﬂammatory syndrome
n  ultrasound-guided  microbiopsy  is  the  rule.  Targeting  isiliation  becomes  very  important  and,  if  negative,  further
icro-  and  macrobiopsies  or  skin  biopsies  must  be  taken.
g for 15 days despite medical treatment, in a patient with breast
 transaxial slices. Silicone-only sequences: siliconoma at the lower
oderately hyperintense; b: after injection: moderate enhancement
with anti-inﬂammatory treatment extended 10 days.
mmogram not feasible. Ultrasound difﬁcult to read. No regression
-weighted coronal slice: thickening of the skin and dilation of the
oronal slice after injection. Irregular masses in the superior lateral
ht superior lateral quadrant: grade 3 invasive ductal carcinoma.
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Figure 11. Age 55. History of conservative treatment 1 year ear-
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ulier. Redness around scar on left superior lateral quadrant with
cutaneous edema. Mammogram and ultrasound normal, other than
mild signs of edema. Resolved with anti-inﬂammatories.
Absent  a  target,  a  blind  microbiopsy  may  be  done,  prefer-
ably  in  the  retroareolar  area  if  the  entire  breast  is  red,  or  in
a  localized  inﬂammatory  area.  As  a  last  resort,  a  skin  biopsy
may  be  done  under  local  anesthesia  in  an  inﬂammatory  area.
An  aspiration  biopsy  of  a  suspicious  enlarged  lymph  node
may  be  appropriate  when  the  breast  workup  is  normal.
Treatment
Benign inﬂammatory syndrome
For  puerperal  mastitis,  broad-spectrum  antibiotic  therapy  is
initiated  (erythromycin,  dicloxacillin,  cephalexin).  Breast-
feeding  may  be  continued  [7].
For  mastitis  with  duct  ectasia,  treatment  consists
of  nonsteroidal  anti-inﬂammatories,  or  steroidal  anti-
inﬂammatories  when  the  clinical  signs  are  marked  (palpable
pseudocystic  dilatations).When  the  clinical  radiology  aspect  is  suggestive  of
an  abscess,  a  trial  treatment  prescribed  on  an  emer-
gency  basis  is  the  rule  for  10—15  days,  with  a  combination
of  antibiotics  (pristinamycin,  amoxicillin,  metronidazole)
t
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Figure 12. Age 33. Smoker. Right periareolar redness. a: ﬁrst-line ult
Periareolar abscess; b: follow-up ultrasound after 10 days of medical trea
Medical treatment continued for 8 days with recommendation that patiems,  therapeutic  principles  133
nd anti-inﬂammatories,  (steroidal  or  nonsteroidal).  The
acterial  ﬂora  of  abscesses  that  occur  outside  of  lacta-
ion  is  often  mixed:  Staphylococcus  aureus, aerobic  and
naerobic  streptococcus,  Enterococcus, Proteus  mirabilis,
scherichia  coli. .  .  Broad-spectrum  antibiotic  therapy  is
ndicated,  particularly  in  patients  at  high  risk  for  recur-
ence  (smokers,  obese  subjects)  [14]. The  symptoms  should
mprove  and  disappear  after  that  time  period,  and  the  ultra-
ound  must  be  repeated  at  the  end  of  treatment  to  be  sure
he  signs  have  disappeared.
For  a  recurrent  ﬁstulized  periareolar  abscess,  the  con-
entional  treatment  is  surgical  excision  of  the  duct  once  it
s  quiescent;  the  quality  of  the  excision  is  fundamental  to
void  recurrence.  In  fact,  management  of  these  patients  is
uite  difﬁcult,  since  once  quiescent,  it  is  often  impossible
or  the  surgeon  to  ﬁnd  the  causal  duct.  Any  associated  nipple
nversion  should  be  corrected.  It  is  necessary  to  convince  the
atient  —and  this  is  essential  — that  it  is  absolutely  manda-
ory  to  stop  smoking  to  prevent  the  condition  from  becoming
hronic  [14,15]  (Fig.  12).
Some  authors  suggest  ultrasound-guided  percutaneous
rainage  for  abscesses  larger  than  3  cm  [8].  In  the  Berna
eries  [8],  15  out  of  17  abscesses  improved,  and  in  two  cases,
 persistent  mass  required  a  histologic  diagnosis;  one  was  an
nﬂammatory  granuloma  and  the  other  was  cancer.
In  the  case  of  Mondor’s  disease,  the  diagnosis  is  clinical
nd  the  inﬂammation  resolves  spontaneously  [16]; nons-
eroidal  anti-inﬂammatories  may  be  prescribed;  a  clotting
orkup  is  recommended.
alignant inﬂammatory syndrome
ased  on  its  histopathologic  features  —  dermal  lympho-
ascular  invasion  is  pathognomonic  of  the  condition  —
nﬂammatory  breast  cancer  should  be  considered  a
ocal/regional  disease  as  soon  as  it  is  diagnosed.  This  seri-
us  condition  is  totally  different  from  other  locally  advanced
reast  cancers  (with  attachment  to  deep  structures  or  skin
lceration)  and  management  by  a  trained  multidisciplinary
eam  is  essential.  Staging  should  be  done  before  treatment
s  initiated,  since  metastatic  disease  is  found  at  the  outset
n  approximately  30%  of  cases.  The  standard  workup  consists
f  a  thoracic  and  abdominopelvic  CT  scan  and  a  bone  scan.
rasound: dilated sub-areolar lactiferous duct with thick contents.
tment. Disappearance of clinical signs. Persistence of visible duct.
nt completely stop smoking.
1 M.  Boisserie-Lacroix  et  al.
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TAKE-HOME  MESSAGES
Diagnosis:
• The  term  mastitis  describes  an  inﬂammation,  but  is
not  synonymous  with  infection.
• Infection  is  the  most  common  cause  of  inﬂammatory
syndrome.
• History-taking  is  essential  in  the  search  for  an
infectious  risk  factor.
• A  mammary  abscess  is  always  visible  on  the
ultrasound.
Strategy:
• Clinical  and  ultrasound  follow-up  should  be
scheduled  after  the  medical  trial  treatment.
• Percutaneous  biopsies  are  required  when  clinical  or
radiological  signs  persist  despite  15  days  of  medical
treatment.
Treatment:
• Since  a  signiﬁcant  association  has  been  found
between  smoking  and  periareolar  abscesses,
cessation  is  imperative.
• Neoadjuvant  chemotherapy  is  administered  in  cases
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ased  on  the  currently  available  data,  a  PET  scan  is  not  part
f  the  standard  workup.
In  the  absence  of  conﬁrmed  metastatic  disease,  surgery
nd  radiation  therapy  are  part  of  the  treatment  plan  [17].
kin  involvement  at  the  time  of  diagnosis  represents  a  con-
raindication  to  initial  surgery,  due  to  the  major  risk  of  tumor
esidue  being  the  cause  of  early  cutaneous  recurrences.
eoadjuvant  chemotherapy  is  therefore  routinely  given,  in
rder  to  achieve  sufﬁcient  tumor  regression  to  allow  a  sub-
equent  surgical  procedure.
Due  to  the  rarity  of  the  disease,  there  have  been  no
andomized  studies  comparing  different  treatment  regi-
ens,  and  the  choice  of  chemotherapy  is  therefore  based
n  retrospective  analyses,  small  prospective  studies,  and
xtrapolation  from  randomized  studies  comparing  different
eoadjuvant  chemotherapies  for  noninﬂammatory  tumors.
he  standard  treatment  currently  consists  of  a  combination
f  an  anthracycline  and  a  taxane  (six  courses).  In  half  the
ases,  the  tumor  shows  HER-2  ampliﬁcation,  and  treatment
ith  trastuzumab  is  then  added  [18]. The  preliminary  results
f  a  French  study  suggest  that  for  HER-2  tumors,  the  addi-
ion  of  an  antiangiogenic,  bevacizumab,  may  signiﬁcantly
ncrease  the  efﬁcacy  of  chemotherapy  and  trastuzumab  in
his  type  of  tumor  subgroup  [19].
If  there  is  good  response  to  chemotherapy,  particularly
ith  regression  of  inﬂammatory  signs,  surgery  should  rou-
inely  be  considered  based  on  retrospective  studies.  Due
o  the  characteristics  of  these  tumors,  that  surgery  should
onsist  of  a  radical  mastectomy  without  preservation  of  the
kin.  Due  to  the  wide  tumor  dissemination  in  the  breast  and
he  frequency  of  axillary  lymph  node  involvement  (55—85%
f  cases),  axillary  resection  with  sentinal  lymph  node  dis-
ection  is  not  a  consideration.  Lymph  node  dissection  is
outinely  done.  This  surgery  is  always  followed  by  radia-
ion  of  the  entire  chest  wall  as  well  as  the  supra-  and
ub-clavicular  and  internal  mammary  lymph  node  areas.
mmediate  breast  reconstruction  is  not  recommended,  but
ay  be  done  subsequently.
Surgery  is  contraindicated  as  long  as  the  inﬂamma-
ory  phenomena  persist  and,  if  neoadjuvant  chemotherapy
ails,  radiation  therapy  should  be  given  before  subsequently
econsidering  a  surgical  procedure.
One-third  of  all  tumors  express  steroid  receptors  (estra-
iol  and/or  progesterone)  and  hormone  therapy  for  at  least
 years  is  then  suggested  after  local/regional  treatment  is
ompleted  [20].
Subsequent  monitoring  includes  a  clinical  examination
very  4—6  months,  as  well  as  an  annual  contralateral  mam-
ogram.  Despite  a  more  severe  prognosis,  all  learned
ocieties  agree  not  to  recommend  any  other  routine  diag-
ostic  tests  since  no  beneﬁt  has  ever  been  found  from  early
iagnosis  of  metastatic  dissemination  for  which  there  is  no
nown  cure.
onclusion
nﬂammatory  syndrome  is  one  of  the  rare  emergency  breast
ituations.  It  has  a  benign  infectious  etiology  in  most  cases
nd  disappears  with  medical  treatment,  with  no  need  for
urther  investigation  [21]. A  trial  treatment  should  not  delay
ncologic  management.
1
2
3
4of  inﬂammatory  breast  cancer.
linical case
rs.  B.,  age  57,  had  2  years  of  conservative  treatment  for
rade  2  invasive  ductal  carcinoma  of  the  right  inferior  lat-
ral  quadrant.  Her  last  follow-up  breast  sonogram  was  done
0  months  earlier.
She  was  seen  for  a  moderate  inﬂammatory  syndrome  of
hat  inferior  lateral  quadrant;  the  scar  was  thickened  but
here  was  no  palpable  mass.  No  enlarged  axillary  lymph
odes.  No  fever.
uestion 1
hat  imaging  studies  do  you  order?
.  None.
.  Ultrasound.
.  Mammogram.
.  MRI.
nswer
,  3.  It  is  legitimate  to  redo  a  full  conventional  workup,
nasmuch  as  the  due  date  for  the  annual  follow-up  is
pproaching.  An  MRI  would  be  indicated  immediately  only
f  the  mammogram  and  ultrasound  were  difﬁcult  to  read.
uestion 2
ased  on  the  mammogram  (Fig.  13)  and  the  ultrasound
Fig.  14)  you  do,  what  do  you  suggest  to  Mrs.  B.?
.  Antibiotic  and  anti-inﬂammatory  treatment.
.  An  MRI.
.  An  ultrasound-guided  biopsy.
.  Nothing;  monitoring  at  1 year.
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Answer
1.  The  mammogram  (Fig.  13)  shows  moderate  post-
treatment  aspects  and  a  clear  image  of  a  fatty  cyst,  which
appears  to  have  mixed  echogenicity  on  the  ultrasound
(Fig.  14).  Subcutaneous  lymphatic  vessels  are  visible,  indi-
cating  edema.
This  inﬂammatory  syndrome  should  be  treated  for
10—15  days,  followed  by  clinical  and  ultrasound  follow-up.
Question 3
The  inﬂammatory  syndrome  clearly  regresses  but  does  not
completely  disappear.
An  MRI  is  done.  You  have  a  T2-weighted  image  (Fig.  15)
and  a  late  image  after  fat  saturation  injection  (Fig.  16).
What  is  your  course  of  action?
1. ACR  2.  Continue  anti-inﬂammatory  therapy  for  1  week
and  repeat  the  annual  follow-up.
2. ACR  3.  Follow-up  MRI  in  4  months.
3. ACR  4.  Ultrasound-guided  biopsy.
Figure 13. Mammogram, lateral. Post-treatment aspects with a
clear image, ﬁnely rimmed with fatty cyst.
Figure 14. Ultrasound: heterogeneous mass with hyperechoic
range and a subsequent mitigation for fatty necrosis.
Figure 15. T1-weighted MRI: mass to fat content.
Figure 16. MRI after injection: ﬁne annular enhancement of the
mass, localized skin enhancement. Inﬂammatory reaction to fatty
n
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Recrosis.
nswer
.  The  MRI  was  done  because  the  inﬂammatory  syndrome
ad  not  completely  disappeared.  It  shows  a T2  hypersig-
al  with  mass  effect,  therefore  fat  content  (Fig.  15),  with
ne  annular  enhancement  indicating  inﬂammation  (Fig.  16).
here  is  no  sign  of  recurrence.
This  was  an  inﬂammatory  reaction  to  fatty  necrosis.  The
nﬂammatory  syndrome  ﬁnally  disappeared  in  a  total  of
 month.
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